Prevention of hyperoxia-mediated pulmonary inflammation in neonatal rats by caffeine
- 9 August 2012
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 41 (4) , 966-973
Abstract
In preterm human infants, briefly elevated concentrations of oxygen are associated with a prolonged increase in blood chemokine concentrations and the development of bronchopulmonary dysplasia (BPD). Caffeine given to preterm infants for the prevention or treatment of apnoea has been shown to reduce the rate of BPD.We tested the hypotheses that infant rats exposed to a combination of caffeine and hyperoxia would be less susceptible to lung injury than those exposed to hyperoxia alone and that caffeine decreases the pulmonary tissue expression of chemokines and leukocyte influx following hyperoxia.Using 6-day-old rat pups, we demonstrated that 24 h of 80% oxygen exposure caused pulmonary recruitment of neutrophils and macrophages. High levels of oxygen upregulated the expression of: the CXC chemokines, cytokine-induced neutrophil chemoattractant-1 and macrophage inflammatory protein-2; the CC-chemokine monocyte chemoattractant protein-1; the pro-inflammatory cytokines tumour necrosis factor-α and interleukin-6, as measured by realtime PCR after the administration of caffeine (10 mg·kg−1body weight); and attenuated chemokine and cytokine upregulation, as well as the influx of CD11b+, ED-1+and myeloperoxidase+leukocytes.These experiments suggest that protective effects of caffeine in the neonatal lung are mediated, at least in part, by reduction of pulmonary inflammation.Keywords
This publication has 27 references indexed in Scilit:
- Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research NetworkPediatrics, 2010
- Caffeine for Apnea of Prematurity Trial: Benefits May Vary in SubgroupsThe Journal of Pediatrics, 2010
- Preterm Resuscitation With Low Oxygen Causes Less Oxidative Stress, Inflammation, and Chronic Lung DiseasePediatrics, 2009
- Animal derived surfactant extract for treatment of respiratory distress syndromeCochrane Database of Systematic Reviews, 2009
- Effect of caffeine on respiratory muscle strength and lung function in prematurely born, ventilated infantsEuropean Journal of Pediatrics, 2009
- Chronic Lung Disease after Premature BirthNew England Journal of Medicine, 2007
- Caffeine Therapy for Apnea of PrematurityNew England Journal of Medicine, 2006
- Methylxanthine treatment for apnea in preterm infants2001
- The New BPD: An Arrest of Lung DevelopmentPediatric Research, 1999
- Vitamin A Supplementation for Extremely-Low-Birth-Weight InfantsNew England Journal of Medicine, 1999